Skip to content
2000
  1. Home
  2. A-Z Publications
  3. CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders)
  4. Volume 24, Issue 1
  5. Article
Volume 24, Issue 1
  • ISSN: 1871-5273
  • E-ISSN:

Abstract

Background

Gliomas are the most frequent, heterogeneous group of tumors arising from glial cells, characterized by difficult monitoring, poor prognosis, and fatality. Tissue biopsy is an established procedure for tumor cell sampling that aids diagnosis, tumor grading, and prediction of prognosis.

Materials and Methods

We studied and compared the levels of liquid biopsy markers in patients with different grades of glioma. Also, we tried to prove the potential association between glioma and specific blood group antigens.

Results

78 patients were found, among whom the maximum percentage with glioblastoma had blood group O+ (53.8%). The second highest frequency had blood group A+ (20.4%), followed by B+ (9.0%) and A- (5.1%), and the least with O-. Liquid biopsy biomarkers included Alanine Aminotransferase (ALT), Lactate Dehydrogenase (LDH), lymphocytes, Urea, Alkaline phosphatase (AST), Neutrophils, and C-Reactive Protein (CRP). The levels of all the components increased significantly with the severity of the glioma, with maximum levels seen in glioblastoma (grade IV), followed by grade III and grade II, respectively.

Conclusion

Gliomas have significant clinical challenges due to their progression with heterogeneous nature and aggressive behavior. A liquid biopsy is a non-invasive approach that aids in setting up the status of the patient and figuring out the tumor grade; therefore, it may show diagnostic and prognostic utility. Additionally, our study provides evidence to prove the role of ABO blood group antigens in the development of glioma. However, future clinical research on liquid biopsy will improve the sensitivity and specificity of these tests and confirm their clinical usefulness to guide treatment approaches.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnsnddt/10.2174/0118715273306577240612053957
2024-07-02
2024-11-22

  • From This Site

    /content/journals/cnsnddt/10.2174/0118715273306577240612053957
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. NafeR. HattingenE. The spectrum of molecular pathways in gliomas : An up-to-date review.Biomedicines2023118228110.3390/biomedicines1108228137626776
     [Google Scholar]
  2. WangL.M. Human brain and spinal cord tumors: From bench to bedside.In: The Path to Bedside ManagementSpringer International Publishing20232130
     [Google Scholar]
  3. PaganoC. NavarraG. CoppolaL. SavareseB. AviliaG. GiarraA. PaganoG. MaranoA. TrifuoggiM. BifulcoM. LaezzaC. Impacts of environmental pollution on brain tumorigenesis.Int. J. Mol. Sci.2023245504510.3390/ijms2405504536902485
     [Google Scholar]
  4. FišereI. GromaV. SvirskisŠ. StrautmaneE. GardovskisA. Evaluation of clinical manifestations of hemorrhoidal disease, carried out surgeries and prolapsed anorectal tissues: Associations with ABO blood groups of patients.J. Clin. Med.20231215511910.3390/jcm1215511937568521
     [Google Scholar]
  5. AbegazS.B. Human ABO blood groups and their associations with different diseases.BioMed Res. Int.202120211910.1155/2021/662906033564677
     [Google Scholar]
  6. GhamdiF.A. NaqviS. AlabassiF.A. AlhayyaniS. BaigM.R. KumarV. AnwarF. Alterations in clinical characteristics of blood donors post COVID-19 recovery.Curr. Pharm. Des.2022281298199210.2174/138161282866622032212322535319357
     [Google Scholar]
  7. QinL. GaoD. WangQ. ZhengX. WangJ. ChenX. FuD. MaH. TanJ. YinQ. ABO blood group and the risk and prognosis of lymphoma.J. Inflamm. Res.20231676977810.2147/JIR.S40181836855543
     [Google Scholar]
  8. CuiH. QuY. ZhangL. ZhangW. YanP. YangC. ZhangM. BaiY. TangM. WangY. ChenL. XiaoC. ZouY. LiuY. ZhangL. YangY. YaoY. LiJ. LiuZ. YangC. JiangX. ZhangB. Epidemiological and genetic evidence for the relationship between ABO blood group and human cancer.Int. J. Cancer2023153232033010.1002/ijc.3453337074298
     [Google Scholar]
  9. LiuY. ChenS. ShenW. QuX. LiS. ShiY. Construction and validation of a gastric cancer diagnostic model based on blood groups and tumor markers.J. Cancer202415372973610.7150/jca.8819038213731
     [Google Scholar]
  10. KimJ. YuanC. AmundadottirL.T. WolpinB.M. KleinA.P. RischH.A. KraftP. RischH.A. KraftP. Relationship between ABO blood group alleles and pancreatic cancer is modulated by secretor (FUT2) genotype, but not Lewis antigen (FUT3) genotype.Cancer Epidemiol. Biomarkers Prev.20233291242124810.1158/1055‑9965.EPI‑23‑000937342060
     [Google Scholar]
  11. LiaoY. LiangT. HeY. MoS. ZhaoS. GaoQ. HanC. PengT. Correlation between ABO blood group and prognosis of hepatectomy for hepatitis B virus-associated hepatocellular carcinoma.Eur. J. Gastroenterol. Hepatol.20233591012102210.1097/MEG.000000000000259337505977
     [Google Scholar]
  12. LilovaZ. HassanF. RiazM. IronsideJ. Ken-DrorG. HanT. SharmaP. Blood group and ischemic stroke, myocardial infarction, and peripheral vascular disease: A meta-analysis of over 145,000 cases and 2,000,000 controls.J. Stroke Cerebrovasc. Dis.202332810721510.1016/j.jstrokecerebrovasdis.2023.10721537336185
     [Google Scholar]
  13. JajoskyR.P. WuS.C. ZhengL. JajoskyA.N. JajoskyP.G. JosephsonC.D. HollenhorstM.A. SacksteinR. CummingsR.D. ArthurC.M. StowellS.R. ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies.iScience202326110579810.1016/j.isci.2022.10579836691627
     [Google Scholar]
  14. JungJ.Y. OhJ.H. LeeD.H. LeeS. ChungJ.H. Blood Type B antigen modulates cell migration through regulating cdc42 expression and activity in HaCaT cells.J. Cell. Physiol.2013228112243225110.1002/jcp.2439323625752
     [Google Scholar]
  15. GuoX. GuL. LiY. ZhengZ. ChenW. WangY. WangY. XingH. ShiY. LiuD. YangT. XiaY. LiJ. WuJ. ZhangK. LiangT. WangH. LiuQ. JinS. QuT. GuoS. LiH. WangY. MaW. Histological and molecular glioblastoma, IDH-wildtype: A real-world landscape using the 2021 WHO classification of central nervous system tumors.Front. Oncol.202313120081510.3389/fonc.2023.120081537483487
     [Google Scholar]
  16. ParkY.W. VollmuthP. Foltyn‐DumitruM. SahmF. AhnS.S. ChangJ.H. KimS.H. The 2021 WHO classification for gliomas and implications on imaging diagnosis: Part 1-key points of the fifth edition and summary of imaging findings on adult-type diffuse gliomas.J Magn Reson Imaging2023583677689
     [Google Scholar]
  17. ToaderC. EvaL. CosteaD. CorlatescuA.D. Covache-BusuiocR.A. BratuB.G. GlavanL.A. CostinH.P. PopaA.A. CiureaA.V. Low-grade gliomas: Histological subtypes, molecular mechanisms, and treatment strategies.Brain Sci.20231312170010.3390/brainsci1312170038137148
     [Google Scholar]
  18. van den BentM.J. GeurtsM. FrenchP.J. SmitsM. CapperD. BrombergJ.E.C. ChangS.M. Primary brain tumours in adults.Lancet2023402104121564157910.1016/S0140‑6736(23)01054‑137738997
     [Google Scholar]
  19. ReussD.E. Updates on the WHO diagnosis of IDH-mutant glioma.J. Neurooncol.2023162346146910.1007/s11060‑023‑04250‑536717507
     [Google Scholar]
  20. AldecoaI. Practice guidelines for the diagnosis of glioblastoma.In: New Insights Into Glioblastoma.Elsevier2023113210.1016/B978‑0‑323‑99873‑4.00011‑6
     [Google Scholar]
  21. AlimohamadiM. LarijaniA. Pour-RashidiA. FarzinM. EbrahimiH. RahmaniM. HendiK. YarandiK.K. AghajanianS. ShiraniM. Comparative analysis of the prognostic significance of IDH, TERT, EGFR and MGMT status in patients with adult Non-H3-altered grade 4 Gliomas: A prospective cohort study.World Neurosurg.2023181e628e63937914076
     [Google Scholar]
  22. WuY. WangX. ZhangM. WuD. Molecular biomarkers and recent liquid biopsy testing progress: A review of the application of biosensors for the diagnosis of gliomas.Molecules20232815566010.3390/molecules2815566037570630
     [Google Scholar]
  23. OrzanF. De BaccoF. LazzariniE. CrisafulliG. GaspariniA. DipasqualeA. BaraultL. MacagnoM. PersicoP. PessinaF. BonoB. GiordanoL. ZeppaP. MelcarneA. CassoniP. GarbossaD. SantoroA. ComoglioP.M. IndraccoloS. SimonelliM. BoccaccioC. Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation.Clin. Cancer Res.20232971252126610.1158/1078‑0432.CCR‑22‑290336648487
     [Google Scholar]
  24. Pilotto HemingC. Niemeyer FilhoP. Moura-NetoV. AranV. Recent advances in the use of liquid biopsy to fight central nervous system tumors.Cancer Treat. Res. Commun.20233510070910.1016/j.ctarc.2023.10070937088042
     [Google Scholar]
  25. FangS. LiL. WengS. GuoY. FanX. JiangT. WangY. Altering patterns of sensorimotor network in patients with different pathological diagnoses and glioma‐related epilepsy under the latest glioma classification of the central nervous system.CNS Neurosci. Ther.20232951368137810.1111/cns.1410936740245
     [Google Scholar]
  26. TakanoS. TianW. MatsudaM. YamamotoT. IshikawaE. KanekoM.K. YamazakiK. KatoY. MatsumuraA. Detection of IDH1 mutation in human gliomas: Comparison of immunohistochemistry and sequencing.Brain Tumor Pathol.201128211512310.1007/s10014‑011‑0023‑721344322
     [Google Scholar]
  27. Al-SawatA. AlswatS. AlosaimiR. AlharthiM. AlsuwatM. AlhasaniK. AlharthiW. Relationship between ABO Blood group and the risk of colorectal cancer: A retrospective multicenter study.J. Clin. Med. Res.202214311912510.14740/jocmr469135464604
     [Google Scholar]
  28. WangC. ZhouJ. WangL. XingT. DaiH. ZhouY. QiL. ZhaoY. HuangC. LiD. LiH. LiM.J. LiuB. ZhengH. ChenK. LiL. ABO blood groups and expression of blood group antigens of epithelial ovarian cancer in Chinese women.Cancer Med.20231267498750710.1002/cam4.547636415180
     [Google Scholar]
  29. AllouhM.Z. Al BarbarawiM.M. HiasatM.Y. Al-QarallehM.A. AbabnehE.I. Glioblastoma and ABO blood groups: Further evidence of an association between the distribution of blood group antigens and brain tumours.Blood Transfus.201715654354727416574
     [Google Scholar]
  30. TurowskiK. CzochraM. ABO blood groups in glioblastoma multiforme.Neurol. Neurochir. Pol.1979132173176221850
     [Google Scholar]
  31. AkcaZ. MutluH. ErdenA. BüyükcelikA. SezerE. InalA. The relationship between ABO blood group and glioblastoma multiforme.Med. Sci.2014341639164710.5455/medscience.2014.03.8160
     [Google Scholar]
  32. PatidarG.K. DhimanY. HazarikaA. Association of ABO blood group antigen and neurological tumors.J. Neuroanaesthesiol. Crit. Care.2022902093098
     [Google Scholar]
  33. AzachiW.B. DakopK.M. Blood Groups: More than Inheritance of Antigenic Substances : Susceptibility to Some DiseasesIntechOpen202210.5772/intechopen.94700
     [Google Scholar]
  34. SinghS. DeoraH. NeyazA. DasK.K. MehrotraA. SrivastavaA.K. BehariS. JaiswalA.K. JaiswalS. Trends in clinico-epidemiology profile of surgically operated glioma patients in a tertiary care center over 12 years—through the looking glass!Egypt. J. Neurosurg.20213613210.1186/s41984‑021‑00118‑w
     [Google Scholar]
  35. GatesE.D.H. WeinbergJ.S. PrabhuS.S. LinJ.S. HamiltonJ. HazleJ.D. FullerG.N. BaladandayuthapaniV. FuentesD.T. SchellingerhoutD. Estimating local cellular density in glioma using MR imaging data.AJNR Am. J. Neuroradiol.202142110210810.3174/ajnr.A688433243897
     [Google Scholar]
  36. GirardiF. MatzM. StillerC. YouH. Marcos GrageraR. ValkovM.Y. BulliardJ.L. DeP. MorrisonD. WannerM. O’BrianD.K. Saint-JacquesN. ColemanM.P. AllemaniC. BouzbidS. Hamdi-ChérifM. KaraL. MeguenniK. RegagbaD. BayoS. Cheick BougadariT. ManrajS.S. BendahhouK. LadipoA. OgunbiyiO.J. SomdyalaN.I.M. ChaplinM.A. MorenoF. CalabranoG.H. EspinolaS.B. Carballo QuinteroB. FitaR. LaspadaW.D. IbañezS.G. LimaC.A. Da CostaA.M. De SouzaP.C.F. ChavesJ. LaporteC.A. CuradoM.P. de OliveiraJ.C. VenezianoC.L.A. VenezianoD.B. AlmeidaA.B.M. LatorreM.R.D.O. RebeloM.S. SantosM.O. Azevedo e SilvaG. GalazJ.C. Aparicio AravenaM. Sanhueza MonsalveJ. HerrmannD.A. VargasS. HerreraV.M. UribeC.J. BravoL.E. GarciaL.S. Arias-OrtizN.E. MorantesD. JuradoD.M. Yépez ChamorroM.C. DelgadoS. RamirezM. Galán AlvarezY.H. TorresP. Martínez-ReyesF. JaramilloL. QuintoR. CastilloJ. MendozaM. CuevaP. YépezJ.G. BhakkanB. DeloumeauxJ. JoachimC. MacniJ. CarrilloR. Shalkow KlincovsteinJ. Rivera GomezR. PerezP. PoquiomaE. Tortolero-LunaG. ZavalaD. AlonsoR. BarriosE. EckstrandA. NikiforukC. WoodsR.R. NoonanG. TurnerD. KumarE. ZhangB. DowdenJ.J. DoyleG.P. Saint-JacquesN. WalshG. AnamA. DeP. McClureC.A. VriendsK.A. BertrandC. RamanakumarA.V. DavisL. KozieS. FreemanT. GeorgeJ.T. AvilaR.M. O’BrienD.K. HoltA. AlmonL. KwongS. MorrisC. RycroftR. MuellerL. PhillipsC.E. BrownH. CromartieB. RuterbuschJ. SchwartzA.G. LevinG.M. WohlerB. BayaklyR. WardK.C. GomezS.L. McKinleyM. CressR. DavisJ. HernandezB. JohnsonC.J. MorawskiB.M. RuppertL.P. BentlerS. CharltonM.E. HuangB. TuckerT.C. DeapenD. LiuL. HsiehM.C. WuX.C. SchwennM. SternK. GershmanS.T. KnowltonR.C. AlversonG. WeaverT. DesaiJ. RogersD.B. Jackson-ThompsonJ. LemonsD. ZimmermanH.J. HoodM. Roberts-JohnsonJ. HammondW. ReesJ.R. PawlishK.S. StroupA. KeyC. WigginsC. KahnA.R. SchymuraM.J. RadhakrishnanS. RaoC. GiljahnL.K. SlocumbR.M. DabbsC. EspinozaR.E. AirdK.G. BeranT. RubertoneJ.J. SlackS.J. OhJ. JanesT.A. SchwartzS.M. ChiodiniS.C. HurleyD.M. WhitesideM.A. RaiS. WilliamsM.A. HergetK. SweeneyC. KachajianJ. Keitheri CheteriM.B. Migliore SantiagoP. BlankenshipS.E. ConawayJ.L. BorchersR. MalickiR. EspinozaJ. GrandpreJ. WeirH.K. WilsonR. EdwardsB.K. MariottoA. Rodriguez-GalindoC. WangN. YangL. ChenJ.S. ZhouY. HeY.T. SongG.H. GuX.P. MeiD. MuH.J. GeH.M. WuT.H. LiY.Y. ZhaoD.L. JinF. ZhangJ.H. ZhuF.D. JunhuaQ. YangY.L. JiangC.X. BiaoW. WangJ. LiQ.L. YiH. ZhouX. DongJ. LiW. FuF.X. LiuS.Z. ChenJ.G. ZhuJ. LiY.H. LuY.Q. FanM. HuangS.Q. GuoG.P. ZhaolaiH. WeiK. ChenW.Q. WeiW. ZengH. DemetriouA.V. MangW.K. NganK.C. KatakiA.C. KrishnatreyaM. JayalekshmiP.A. SebastianP. GeorgeP.S. MathewA. NandakumarA. MalekzadehR. RoshandelG. Keinan-BokerL. SilvermanB.G. ItoH. KoyanagiY. SatoM. ToboriF. NakataI. TeramotoN. HattoriM. KaizakiY. MokiF. SugiyamaH. UtadaM. NishimuraM. YoshidaK. KurosawaK. NemotoY. NarimatsuH. SakaguchiM. KanemuraS. NaitoM. NarisawaR. MiyashiroI. NakataK. MoriD. YoshitakeM. OkiI. FukushimaN. ShibataA. IwasaK. OnoC. MatsudaT. NimriO. JungK.W. WonY.J. AlawadhiE. ElbasmiA. Ab MananA. AdamF. NansalmaaE. TudevU. OchirC. Al KhaterA.M. El MistiriM.M. LimG.H. TeoY.Y. ChiangC.J. LeeW.C. BuasomR. SangrajrangS. SuwanrungruangK. VatanasaptP. DaoprasertK. PongnikornD. LeklobA. SangkitipaiboonS. GeaterS.L. SriplungH. CeylanO. KögI. DiricanO. KöseT. GurbuzT. KaraşahinF.E. TurhanD. AktaşU. HalatY. EserS. YakutC.I. AltinisikM. CavusogluY. TürkköylüA. ÜçüncüN. HacklM. ZborovskayaA.A. AleinikovaO.V. HenauK. Van EyckenL. AtanasovT.Y. ValerianovaZ. ŠekerijaM. DušekL. ZvolskýM. Steinrud MørchL. StormH. Wessel SkovlundC. InnosK. MägiM. MalilaN. SeppäK. JéguJ. VeltenM. CornetE. TroussardX. BouvierA.M. GuizardA.V. BouvierV. LaunoyG. Dabakuyo YonliS. PoillotM.L. MaynadiéM. MounierM. VaconnetL. WoronoffA.S. DaoulasM. RobaszkiewiczM. ClavelJ. PoulalhonC. DesandesE. LacourB. BaldiI. AmadeoB. CoureauG. MonnereauA. OrazioS. AudoinM. D’AlmeidaT.C. BoyerS. HammasK. TrétarreB. ColonnaM. DelafosseP. PlouvierS. Cowppli-BonyA. MoliniéF. BaraS. GanryO. Lapôtre-LedouxB. Daubisse-MarliacL. BossardN. UhryZ. EstèveJ. StabenowR. Wilsdorf-KöhlerH. EberleA. LuttmannS. LöhdenI. NenneckeA.L. KieschkeJ. SirriE. JustenhovenC. ReinwaldF. HolleczekB. EisemannN. KatalinicA. AsquezR.A. KumarV. PetridouE. ÓlafsdóttirE.J. TryggvadóttirL. MurrayD.E. WalshP.M. SundsethH. HarneyM. MazzoleniG. VittadelloF. CovielloE. CuccaroF. GalassoR. SampietroG. GiacominA. MagoniM. ArdizzoneA. D’ArgenzioA. Di PrimaA.A. IppolitoA. LavecchiaA.M. Sutera SardoA. GolaG. BallotariP. GiacomazziE. FerrettiS. Dal MasoL. SerrainoD. CelesiaM.V. FilibertiR.A. PannozzoF. MelcarneA. QuartaF. AndreanoA. RussoA.G. CarrozziG. CirilliC. Cavalieri d’OroL. RognoniM. FuscoM. VitaleM.F. UsalaM. CusimanoR. MazzuccoW. MichiaraM. SgargiP. BoschettiL. MarguatiS. ChiarandaG. SeghiniP. MauleM.M. MerlettiF. SpataE. TuminoR. MancusoP. CassettiT. SassatelliR. FalciniF. GiorgettiS. CaiazzoA.L. CavalloR. PirasD. BellaF. MadedduA. FanettiA.C. MasperoS. CaroneS. MincuzziA. CandelaG. ScuderiT. GentiliniM.A. RizzelloR. RossoS. CaldarellaA. IntrieriT. BianconiF. ContieroP. TagliabueG. RuggeM. ZorziM. BeggiatoS. BrustolinA. GattaG. De AngelisR. VicentiniM. ZanettiR. StracciF. MaurinaA. OniščukaM. MousaviM. SteponavicieneL. VincerževskienėI. AzzopardiM.J. CallejaN. SieslingS. VisserO. JohannesenT.B. LarønningenS. TrojanowskiM. MacekP. MierzwaT. RachtanJ. RosińskaA. KępskaK. KościańskaB. BarnaK. SulkowskaU. GebauerT. ŁapińskaJ.B. Wójcik-TomaszewskaJ. MotnykM. PatroA. GosA. SikorskaK. Bielska-LasotaM. DidkowskaJ.A. WojciechowskaU. Forjaz de LacerdaG. RegoR.A. CarritoB. PaisA. BentoM.J. RodriguesJ. LourençoA. Mayer-da-SilvaA. CozaD. TodescuA.I. ValkovM.Y. GusenkovaL. LazarevichO. PrudnikovaO. VjushkovD.M. EgorovaA. OrlovA. PikalovaL.V. ZhuikovaL.D. AdamcikJ. Safaei DibaC. ZadnikV. ŽagarT. De-La-CruzM. Lopez-de-MunainA. AlemanA. RojasD. ChillarónR.J. NavarroA.I.M. Marcos-GrageraR. PuigdemontM. Rodríguez-BarrancoM. Sánchez PerezM.J. Franch SuredaP. Ramos MontserratM. Chirlaque LópezM.D. Sánchez GilA. ArdanazE. GuevaraM. Cañete-NietoA. Peris-BonetR. CarullaM. GalceranJ. AlmelaF. SabaterC. KhanS. PetterssonD. DickmanP. StaehelinK. StruchenB. Egger HayozC. RapitiE. SchaffarR. WentP. MousaviS.M. BulliardJ-L. Maspoli-ConconiM. KuehniC.E. RedmondS.M. BordoniA. OrtelliL. ChioleroA. KonzelmannI. RohrmannS. WannerM. BroggioJ. RashbassJ. StillerC. FitzpatrickD. GavinA. MorrisonD.S. ThomsonC.S. GreeneG. HuwsD.W. GraysonM. RawcliffeH. AllemaniC. ColemanM.P. Di CarloV. GirardiF. MatzM. MinicozziP. SanzN. SsenyongaN. JamesD. StephensR. ChalkerE. SmithM. GugusheffJ. YouH. Qin LiS. DugdaleS. MooreJ. PhilpotS. PfeifferR. ThomasH. Silva RagainiB. VennA.J. EvansS.M. Te MarveldeL. SaviettoV. TrevithickR. AitkenJ. CurrowD. FowlerC. LewisC. Global survival trends for brain tumors, by histology: Analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3).Neuro-oncol.202325358059210.1093/neuonc/noac21736355361
     [Google Scholar]
  37. PaulP. BanerjeeM. A comprehensive view (COUP D’OEIL) of brain tumors from eastern India.World Neurosurg.2023175e1237e124510.1016/j.wneu.2023.04.10437427703
     [Google Scholar]
  38. JarmuzekP. KozlowskaK. DefortP. KotM. Zembron-LacnyA. Prognostic values of systemic inflammatory immunological markers in glioblastoma: A systematic review and meta-analysis.Cancers20231513333910.3390/cancers1513333937444448
     [Google Scholar]
  39. ElguindyM. YoungJ.S. MondalI. LuR.O. HoW.S. Glioma–immune cell crosstalk in tumor progression.Cancers202416230810.3390/cancers1602030838254796
     [Google Scholar]
  40. Frontiñán-RubioJ. Llanos-GonzálezE. García-CarpinteroS. PeinadoJ.R. Ballesteros-YáñezI. RayoM.V. de la FuenteJ. Pérez-GarcíaV.M. Perez-RomasantaL.A. MalumbresM. AlcaínF.J. Durán-PradoM. CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation.Cell Oncol.2023461657710.1007/s13402‑022‑00734‑036319818
     [Google Scholar]
  41. CaverzánM.D. BeaugéL. OlivedaP.M. Cesca GonzálezB. BühlerE.M. IbarraL.E. Exploring monocytes-macrophages in immune microenvironment of glioblastoma for the design of novel therapeutic strategies.Brain Sci.202313454210.3390/brainsci1304054237190507
     [Google Scholar]
  42. MaasR.R. SoukupK. FournierN. MassaraM. GallandS. KorneteM. WischnewskiV. LourencoJ. CrociD. Álvarez-PradoÁ.F. The local microenvironment drives activation of neutrophils in human brain tumors.Cell2023186214546456610.1016/j.cell.2023.08.043
     [Google Scholar]
  43. RugambwaT.K. AbdihamidO. ZhangX. PengY. CaiC. ShenH. ZengS. QiuW. Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.Front. Oncol.202313118124810.3389/fonc.2023.118124838023176
     [Google Scholar]
  44. FörnvikK. MaddahiA. LiljedahlE. OstherK. SalfordL.G. RedebrandtH.N. What is the role of CRP in glioblastoma?Cancer Treat. Res. Commun.20212610029310.1016/j.ctarc.2020.10029333385735
     [Google Scholar]
  45. CarranoA. JuarezJ.J. IncontriD. IbarraA. Guerrero CazaresH. Sex-specific differences in glioblastoma.Cells2021107178310.3390/cells1007178334359952
     [Google Scholar]
  46. RosalesC. Neutrophils at the crossroads of innate and adaptive immunity.J. Leukoc. Biol.2020108137739610.1002/JLB.4MIR0220‑574RR32202340
     [Google Scholar]
  47. Friedmann-MorvinskiD. HambardzumyanD. Monocyte-neutrophil entanglement in glioblastoma.J. Clin. Invest.20231331e16345110.1172/JCI16345136594465
     [Google Scholar]
  48. CooperJ. PastorelloY. SlevinM. A meta-analysis investigating the relationship between inflammation in autoimmune disease, elevated CRP, and the risk of dementia.Front. Immunol.202314108757110.3389/fimmu.2023.108757136776896
     [Google Scholar]
  49. AuezovaR. IvanovaN. AkshulakovS. ZhetpisbaevB. KozhakhmetovaA. RyskeldiyevN. MustafinK. TeltayevD. AuezovaL. Isocitrate dehydrogenase 1 mutation is associated with reduced levels of inflammation in glioma patients.Cancer Manag. Res.2019113227323610.2147/CMAR.S19575431114362
     [Google Scholar]
  50. WachJ. ApallasS. SchneiderM. GüresirA. SchussP. HerrlingerU. VatterH. GüresirE. Baseline serum C-reactive protein and plasma fibrinogen-based score in the prediction of survival in glioblastoma.Front. Oncol.20211165361410.3389/fonc.2021.65361433747971
     [Google Scholar]
  51. HottaT. NakashimaK. HataK. TsubataY. IsobeT. High serum C-reactive protein levels predict survival in patients with treated advanced lung adenocarcinoma.J. Thorac. Dis.20211331476148410.21037/jtd‑20‑312333841940
     [Google Scholar]
  52. MuddobalaiahP. RaviV. ThammannaC.C. SagarB.K.C. SwamyN.S.R. Acid and alkaline phosphatases specific activities and expression as biomarkers in brain tumor grading and correlation of anaplastic oligodendroglioma G-III to meningiomas G-I among brain tumors and their primary culture.J. Chem. Neuroanat.202212510214010.1016/j.jchemneu.2022.10214035914649
     [Google Scholar]
  53. ChenS.L. LiJ.P. LiL.F. ZengT. HeX. Elevated preoperative serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio is associated with better prognosis in patients undergoing curative treatment for gastric adenocarcinoma.Int. J. Mol. Sci.201617691110.3390/ijms1706091127294917
     [Google Scholar]
  54. ChioccaE.A. YuJ.S. LukasR.V. SolomonI.H. LigonK.L. NakashimaH. TriggsD.A. ReardonD.A. WenP. StopaB.M. NaikA. RudnickJ. HuJ.L. KumthekarP. YaminiB. BuckJ.Y. DemarsN. BarrettJ.A. GelbA.B. ZhouJ. LebelF. CooperL.J.N. Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial.Sci. Transl. Med.201911505eaaw568010.1126/scitranslmed.aaw568031413142
     [Google Scholar]
  55. ClapsG. FaouziS. QuidvilleV. ChehadeF. ShenS. VagnerS. RobertC. The multiple roles of LDH in cancer.Nat. Rev. Clin. Oncol.2022191274976210.1038/s41571‑022‑00686‑236207413
     [Google Scholar]
  56. McGovernJ. DolanR.D. SimmonsC.P.L. DalyL.E. RyanA.M. PowerD.G. MaguireD. FallonM.T. LairdB.J. McMillanD.C. Lactate dehydrogenase: Relationship with the diagnostic GLIM criterion for cachexia in patients with advanced cancer.Br. J. Cancer2023128576076510.1038/s41416‑022‑02099‑536517550
     [Google Scholar]
  57. ChenX.Y. ChenJ.Y. ChenY. ChenJ.F. LinN. DingC.Y. KangD.Z. WangD.L. FangW.H. Preoperative serum lactate dehydrogenase level predicts progression and prognosis in patients with glioma.Clin. Neurol. Neurosurg.202120910691210.1016/j.clineuro.2021.10691234509141
     [Google Scholar]
  58. PeiY.Y. ZhangY. LiuZ.R. HeY. YuJ.Y. ZhangR.J. WangJ.J. PengX.C. FangF. Lactate dehydrogenase as promising marker for prognosis of brain metastasis.J. Neurooncol.2022159235936810.1007/s11060‑022‑04070‑z35794505
     [Google Scholar]
/content/journals/cnsnddt/10.2174/0118715273306577240612053957
Loading
Synchronized Glioma Insights: Trends, Blood Group Correlations, Staging Dynamics, and the Vanguard of Liquid Biopsy Advancements
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) 24, 74 (2025); https://doi.org/10.2174/0118715273306577240612053957
/content/journals/cnsnddt/10.2174/0118715273306577240612053957
/content/journals/cnsnddt/10.2174/0118715273306577240612053957
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): blood group; correlations; CRP; glioma; LFT; Liquid biopsy; stages; trends

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test